Galera's synthetic enzyme GC4419, appears to stave off severe oral mucositis, a side effect of cancer treatment.

Tandem Diabetes Care launched a new predictive feature for automatically pausing insulin delivery as a free update for its CGM-enabled insulin pumps.

Tolero Pharmaceuticals has inked a pact to test its CDK9 inhibitor, alvocidib, in combination with AbbVie’s Venclexta in relapsed/refractory AML.

The takeover gives Novo control of a platform that could support development of insulins that respond to glucose.

The imminent departure leaves Pfenex without a CMO as it gears up to file a new drug application (NDA), although Chen will continue to advise the biotech.

The FDA approved the first generic versions of Mylan’s EpiPen and EpiPen Jr, as shortages of the autoinjectors continue.

Males of soybean cyst nematode, or H. glycines, are able reverse neurodegeneration as part of their natural life cycle.

Biohaven’s new formulation of ALS drug riluzole has helped people with social anxiety face the challenge of speaking in public.